Seventeen participants (89%) had HIV-coinfection, 16 of whom were receiving antiretroviral therapy and had a median CD4+ T cell count of 38 cells/μL and HIV viral load (VL) of 443 copies/mL at the time of sample collection (Table 1). The gene discussed is CD4; the disease is coinfection.